Company Filing History:
Years Active: 2022
Title: Sirano Dhe-Paganon: Innovator in Cancer Treatment
Introduction
Sirano Dhe-Paganon is a notable inventor based in Holliston, MA (US). He has made significant contributions to the field of cancer treatment, particularly through his work on USP7 inhibitors. His innovative approach aims to provide new therapeutic options for patients suffering from multiple myeloma and other related diseases.
Latest Patents
Sirano Dhe-Paganon holds a patent for USP7 inhibitors that are useful in treating multiple myeloma. The patent details inhibitors of USP7, which are designed to target cancers and other diseases mediated by USP7. The specific formula and components of these inhibitors are described in the patent documentation.
Career Highlights
Throughout his career, Dhe-Paganon has been associated with the Dana-Farber Cancer Institute Inc., where he has focused on cancer research and treatment innovations. His work has been instrumental in advancing the understanding of USP7's role in cancer biology.
Collaborations
Some of his notable coworkers include Sara Jean Buhrlage and Kenneth Carl Anderson. Their collaborative efforts contribute to the ongoing research and development of effective cancer therapies.
Conclusion
Sirano Dhe-Paganon's work exemplifies the impact of innovative research in the fight against cancer. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment.